A robot has been used to inject a drug into the back of the eye in a world first for the next phase of a landmark clinical trial at Oxford’s John Radcliffe Hospital. Prof Robert MacLaren used the remotely controlled robot to administer a tiny volume of blood dissolving agent tPA under the retina to […]
A psychiatrist at Oxford Health has led a study which might be able to predict who will go on to self-harm again and again. The research, led by Dr Matthew Broome, a psychiatrist at Oxford Health and a researcher at Oxford University’s Department of Psychiatry, analysed the results from 15 previous studies of the relationship between different psychological […]
Emeritus Professor of Clinical Neurology, Professor Christopher Kennard joins the Medical Sciences Division as its new interim Head of Division today, replacing Professor Alastair Buchan, who will be taking a new role as the University’s Head of Brexit Strategy. For the full story on University of Oxford website
A consortium directed by Dr. Kalyanam Shivkumar at UCLA has received a three-year, $8.6 million grant from the National Institutes of Health (NIH). The consortium hopes to map the heart’s nervous system, ultimately developing new treatments for cardiovascular disease. For the full story on department of physiology, anatomy and genetics website
A study led by Dr Belinda Lennox, a consultant psychiatrist at Oxford Health, has found that specific antibodies (proteins usually produced by the body in response to a foreign threat) are associated with the start of schizophrenia. The study, published in the journal Lancet Psychiatry, is the first to identify this association. Full story on Oxford […]
A major University of Oxford genetics research centre that supports Oxford BRC research is to share £118m of new funding. Full story on NIHR Oxford Biomedical Research Centre website
Oxford University’s Wellcome Trust Centre for Human Genetics (WTCHG) and the leading genome analytics company Genomics plc has announced the first sequencing and analysis of multiple human genomes using nanopore technology. The announcement, made on Thursday, December 1, at the Oxford Nanopore Community Meeting in New York City, marks a major breakthrough in sequencing technology. […]
The IKAlliance, a multinational and multidisciplinary consortium created in response to a Horizon 2020 funding call by the European Commission’s Directorate-General Research and Innovation, has officially started its activities with the kick-off meeting held in Brazil over the 4th and 5th December 2016. Full story on Nuffield Department of Medicine website
The University of Oxford launched its first Public Engagement with Research Strategic Plan to an audience of over 100 staff at a reception at the Pitt Rivers Museum on 12th December 2016. Full story on Medical Sciences Division website
EnzBond, a new biotechnology company from Oxford University, has been formed to commercialise in-silico technology, which makes utilising enzymes in drug manufacturing both cost-effective and time-efficient Full story on Oxford University website